Potential and outcomes of surgical treatment of patients with retroperitoneal non-organ liposarcoma invading great vessels
Science and Innovations in Medicine · 2026-03-28 · 11 (2) · 117-122
DOI: 10.35693/sim703846 ↗At a glance
Journal article in Science and Innovations in Medicine, published online on 2026-03-28. Written by Mikael G. Abgaryan and 6 co-authors. 29 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Aim: to demonstrate the feasibility, safety, and efficacy of resection of major arteries (aorta, right/left iliac artery) and veins (inferior vena cava, right/left iliac vein) in patients with retroperitoneal non-organ liposarcomas with major vessel invasion. Material and methods. This retrospective study included patients with retroperitoneal non-organ liposarcomas with major vessel invasion who underwent surgical treatment at the N.N. Blokhin National Medical Research Center of Oncology from 2001 to 2023. This included liposarcoma removal with multi-organ resection and resection of major arteries (aorta, right/left iliac artery) and veins (inferior vena cava, right/left iliac vein). Gore-Tex synthetic grafts were used for vascular reconstruction. In the presence of satisfactory collateral outflow, a circular resection of the inferior vena cava without grafting was performed. Complications of surgical treatment were assessed using the Clavien-Dindo scale. Statistical analysis of the study material was performed using Statistica for Windows v.10 and SPSS v21. Differences in the obtained results were considered statistically significant at a p level of ≤0.05. Survival was calculated using the Kaplan-Meier method, and the significance of differences was assessed using the log-rank test.
Results
The study included 28 patients with retroperitoneal non-organ liposarcomas with invasion of the great vessels: 9 (32.1%) men and 19 (67.9%) women, aged 22 to 73 years (median age 49.5 [42.5; 55.0] years). Eleven patients (39.3%) had a primary tumor, and 17 (60.7%) had a recurrent tumor. In 13 patients (46.4%), liposarcoma corresponded to stage Ib according to the TNM classification, in 6 (21.4%), stage IIIa, and in 9 (32.1%), stage IIIb. Multinodular liposarcoma was diagnosed in 12 cases (42.9%). In 13 patients (46.4%), the tumor had a high degree of differentiation (G1), in 7 (25%), moderate grade (G2), and in 8 (28.6%), low grade (G3). Neoadjuvant chemotherapy (doxorubicin + ifosfamide) was received by 6 patients (21.4%) with a stabilizing effect. All 28 patients underwent radical surgery. Along with liposarcoma removal, resection of the main arteries (aorta, right/left iliac artery) was performed in 9 (32.1%) cases, resection of the main veins (inferior cava, right/left iliac veins) in 13 (46.5%) cases, and resection of arteries and veins in 6 (21.4%) cases. Multiorgan resections of 1-5 organs were performed in 21 (75%) patients. The incidence of surgical complications of class III according to the Clavien-Dindo scale and above was 21.4% (n=6), postoperative mortality was 3.6% (n=1). The follow-up periods for 28 patients ranged from 2.3 to 189.8 months (median 62.5 [14.8; 84.6] months). During this time, disease progression occurred in 20 (71.4%) patients, local recurrence developed in 12 (42.9%), distant metastases in 7 (25%), and both local recurrence and distant metastases in 1 (3.6%). Eight (28.6%) patients died from liposarcoma progression. The overall 1- and 3-year survival rates were 96.4±3.5%, 5-year survival rates were 84.4±8.5%, and 10-year survival rates were 39.8±14.6% (median overall survival was 88.8 [72.3; -] months). The progression-free survival rates of liposarcoma were 84.8±7.0%, 48.9±11.2%, 21.7±9.5%, 5.4±5.3% and 21.7 [12.2; 52.5] months, respectively. Multivariate Cox regression analysis showed that the overall survival of 28 patients with retroperitoneal non-organ liposarcoma with invasion of great vessels was negatively affected by 3 independent factors: low degree of tumor differentiation, the presence of multinodular tumor and the presence of tumor invasion of organs located near the retroperitoneal non-organ liposarcoma, for which multiorgan resection was performed. Progression-free survival in retroperitoneal non-organ liposarcoma with great vessel invasion was statistically significantly negatively impacted by two independent factors: low tumor differentiation and the presence of tumor recurrence.
Conclusion
The results of our study demonstrated that radical surgical treatment of patients with retroperitoneal non-organ liposarcoma with great vessel invasion, including the aorta, is feasible in a specialized clinic. This treatment is associated with an acceptable complication rate and ensures a high overall 5-year survival rate of 84.4±8.5%.
Cite
APA
Abgaryan, M. G., Artamonova, E. V., Kovalenko, E. I., Titova, T. A., Nikulin, M. P., Berdnikov, S. N., & Stilidi, I. S. (2026). Potential and outcomes of surgical treatment of patients with retroperitoneal non-organ liposarcoma invading great vessels. Science and Innovations in Medicine, 11(2), 117-122. https://doi.org/10.35693/sim703846
Vancouver
Abgaryan MG, Artamonova EV, Kovalenko EI, Titova TA, Nikulin MP, Berdnikov SN, et al. Potential and outcomes of surgical treatment of patients with retroperitoneal non-organ liposarcoma invading great vessels. Science and Innovations in Medicine. 2026;11(2):117-122. doi:10.35693/sim703846
BibTeX
@article{Abgaryan2026,
author = {Abgaryan, Mikael G. and Artamonova, Elena V. and Kovalenko, Elena I. and Titova, Tatyana A. and Nikulin, Maksim P. and Berdnikov, Sergei N. and Stilidi, Ivan S.},
title = {Potential and outcomes of surgical treatment of patients with retroperitoneal non-organ liposarcoma invading great vessels},
journal = {Science and Innovations in Medicine},
year = {2026},
volume = {11},
number = {2},
pages = {117--122},
doi = {10.35693/sim703846}
}
EUVIMED